Ansa Biotechnologies Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $9.2M
Latest Deal Amount
  • Investors
  • 5

Ansa Biotechnologies General Information

Description

Provider of a novel dna synthesis technology intended to simplify the biological research process. The company's technology accelerates innovation in biological research and engineering based on polymerase-nucleotide conjugates that have the ability to extend a dna molecule, enabling the healthcare industry to fasten defined nucleotide additions research by tdt while unlocking the potential of enzymatic de novo dna synthesis.

Contact Information

Website
www.ansabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Bonneville Labs, 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States
+1 (248) 000-0000

Ansa Biotechnologies Timeline

201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ansa Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 09-Jul-2020 $9.2M 000.00 Completed Startup
1. Grant 19-Jun-2019 00000 Completed Startup
To view Ansa Biotechnologies’s complete valuation and funding history, request access »

Ansa Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-5 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed-3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed-2 1,113,231 $0.000100 $0.13 $0.13 1x $0.13 4.11%
Seed-1 8,897,294 $0.000100 $0.71 $0.71 1x $0.71 32.74%
To view Ansa Biotechnologies’s complete cap table history, request access »

Ansa Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of a novel dna synthesis technology intended to simplify the biological research process. The company's technol
Biotechnology
Berkeley, CA
11 As of 2021
00.00 0000-00-00
000000000

0000000

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequa
0000000000000
Cambridge, United Kingdom
00 As of 0000
000.00
00000 00000 000.00

000 0000

oris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000000000000
France
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ansa Biotechnologies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nuclera Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000 00000 000.00
000 000000 Venture Capital-Backed France 000 00000 00000000000 00000
000000000 00000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
00000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Ansa Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Daniel Lin-Arlow Ph.D Chief Executive Officer & Board Member
Sebastian Palluk Chief Technology Officer & Board Member
To view Ansa Biotechnologies’s complete executive team members history, request access »

Ansa Biotechnologies Board Members (2)

Name Representing Role Since
Daniel Lin-Arlow Ph.D Ansa Biotechnologies Chief Executive Officer & Board Member 000 0000
Sebastian Palluk Ansa Biotechnologies Chief Technology Officer & Board Member 000 0000
To view Ansa Biotechnologies’s complete board members history, request access »

Ansa Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ansa Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fifty Years Venture Capital Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
Humboldt Fund Venture Capital Minority 000 0000 000000 0
Mubadala Capital-Ventures Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Ansa Biotechnologies’s complete investors history, request access »